Pheochromocytomas Completed Phase Trials for Benzalkonium (DB11105)

Also known as: Pheochromocytoma / Chromaffin cell neoplasm (morphologic abnormality) / Phaeochromocytoma / Pheochromocytoma (morphologic abnormality) / Phaeochromocytoma [Ambiguous]

IndicationStatusPhase
DBCOND0071316 (Pheochromocytomas)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04557072Selective Versus Nonselective Alpha-blockade Prior to Pheochromocytoma Resection - Systematic Review and Meta-analysis